Event Participants
Executives
3 Deole, Dilip (ABP of Finance and Accounts); Mishra, D.N. (Company Secretary); Nayyar, Rakesh (Executive Director and CFO)
Analysts
8 Chamria, Disha (Trinetra Asset Managers); Joshi, Rohan (Individual Investor); Keshri, Santosh (SKK Huf); Khetan, Aditya (SMIFS Institutional Equities); Jimudia, Nirav (Anvil Wealth); Raja, Sailesh (360 ONE Capital Market); Sen, Sahil (Individual Investor); Shah, Vipul Kumar (Sumangal Investments)
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Sales Volume (Manufactured Products) | 70,842 MT | Down 24.5% YoY vs 93,853 MT; decline driven by negligible exports (10-12% of normal) due to West Asia crisis and ~50% drop in non-OEM demand |
| Revenue from Operations | ₹1,693 crores | +22% YoY despite lower volumes; growth driven by significant increase in raw material prices due to West Asia conflict |
| Operating EBITDA | ₹331 crores | +188% YoY; margin at 19.53%, up sharply due to widened international deltas between styrene monomer and downstream products |
| Total EBITDA (incl. Other Income) | ₹348 crores | Margin at 20.3%; other income contributed ~₹17 crores |
| Net Profit After Tax | ₹236 crores | PAT margin of 13.96%; driven by wider global deltas |
| Trading Sales | ~17-18% of top line | Lower than historical levels; management did not provide exact figure |
| Styrene Monomer Price (Current CIF) | ~$1,300/ton | Q1 average ranged $1,350-1,400 with peak above $1,500; prices softened briefly in June but re-escalated with renewed hostilities |
| Current Global Deltas - GPPS | $250-275 | Normalized from peak of +$300+ during quarter; down from Q1 highs |
| Current Global Deltas - HIPS | ~$350 | Normalized from peak of +$400+; Q1 range seen at $275-400 |
| Capex (Approved Projects) | ₹450 crores | Funded entirely through internal accruals |
Geographic & Segment Commentary
Polystyrene (PS): Non-OEM segment demand fell
50% in Q1 due to high prices and gas supply issues for downstream processors; OEM demand was stable and marginally better YoY. Industry-wide demand degrew at similar rates. Import duty exemption on commodity polymers led to unnecessary imports (20,000 tons estimated unofficially), eroding domestic producers' market share. Duty exemption period has ended; duties restored to pre-April 1 levels.EPS (Expandable Polystyrene): Phase 2 expansion completed, taking capacity to 1,43,000 tons per annum. Demand outlook driven by energy-efficient buildings, cold storage, coal supply chain, and construction sectors. Global players shutting down EPS plants noted as favorable supply dynamics. Exports to Europe have been approved but on hold due to shipping disruptions and freight rate spikes.
Compounding & ABS: Compounding capacity expanding from 50,000 to 80,000 tons per annum (commissioning by June 2027); ABS compounds performed very well in Q1 with significant growth anticipated. Management expects full capacity utilization within 2-3 years of commissioning. Terminal ABS nameplate capacity after full expansion will be 1,40,000 tons.
XPS Boards: New line of 150,000 cubic meters wide-width board capacity approved; part of the ₹450 crores (or total ~₹900 crores including all projects) capex program.
Company-Specific & Strategic Commentary
Supply Chain Resilience: All three traditional styrene monomer suppliers in the Gulf region suspended operations due to safety concerns from the West Asia conflict. Company established alternate supply arrangements and met 100% of domestic customer requirements without interruption. Alternative sourcing is structurally more expensive due to longer voyage times, higher freight rates, and reduced shipping availability.
Capacity Expansion Program: Board approved new 80,000 tons per annum polystyrene line at Amdoshi complex (Maharashtra), taking total installed PS capacity from 3,00,000 to 3,80,000 tons per annum by December 2028. Combined with EPS board line and compounding expansion, total capex estimated at ₹450 crores (management later indicated ~₹900 crores for all ongoing projects), funded entirely through internal accruals. All capacities expected to be on board by March 2029.
Product Mix Evolution: Company deliberately focusing on value-added grades (specialty products, ABS compounds) that command premium pricing over industry averages. Maintaining disciplined credit policy (no 40-50 day credit terms offered by competitors); focusing on value-added customer segments with credit discipline. Subsidiary's credit mindset being reformed toward this approach.
Exports Strategy: EPS exports to Europe were initiated last year (small quantities) with grade approvals secured; exports currently on hold due to West Asia disruptions, limited styrene availability, and elevated freight costs. Management committed to resuming and increasing EPS exports to European markets once situation normalizes.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Volume Guidance | No formal guidance for FY27 | Management declined to provide volume guidance given fluid West Asian situation; will assess quarter-by-quarter as situation stabilizes |
| Margins | No formal guidance; directional only | Margins dependent on global deltas; Q1 margins (19.53% EBITDA) described as "aberration" due to exceptionally strong international deltas; expected to normalize over time |
| Capex | ~₹900 crores total | All projects (XPS line, compounding expansion, new PS line) funded through internal accruals; EPS expansion largely complete |
| Capacity Commissioning | June 2027: XPS board (150,000 m³) and compounding (80,000 TPA); December 2028: new PS line (80,000 TPA) | All projects on track; asset turnover expected at 2x on full capacity basis |
| Non-OEM Demand Recovery | Recovering in Q2 FY27 | Management noted non-OEM customers "reconciled" to higher prices as global phenomenon; demand returning to market |
| Compounding Capacity Utilization | Expected within 2-3 years post-commissioning | ABS compounds growth and new applications driving demand; ABS compound market demand supports the expansion |
Risks & Constraints
| Risk | Context |
|---|---|
| West Asia Geopolitical Disruption | Prolonged conflict has suspended all three Gulf styrene plants, disrupted Strait of Hormuz shipping, and escalated freight rates; situation described as "entirely different" from past disruptions (including COVID). No timeline for resolution; renewed escalation in late June has again spiked styrene prices. |
| Margin Normalization Risk | Q1's 19.53% EBITDA margin driven by exceptional global deltas (GPPS +$300+, HIPS +$400+); current deltas have already normalized to $250-275 GPPS and ~$350 HIPS. Management explicitly characterized Q1 margins as "aberration" that will normalize. |
| Import Competition & Duty Waivers | Temporary import duty exemption on commodity polymers (3.5 months) led to unnecessary imports (~20,000 tons in Q1), eroding domestic producer market share. While duties are restored (pre-April 1 levels), recurring policy interventions remain a risk. |
| Non-OEM Demand Vulnerability | Non-OEM segment demand fell ~50% in Q1 due to price resistance and downstream gas supply issues; though recovering, this segment remains sensitive to price levels and macroeconomic conditions. |
| Export Disruption | Exports fell to 10-12% of normal levels due to shipping constraints, longer voyage times, and higher freight rates; export competitiveness impaired until regional situation normalizes. |
| Raw Material Supply Concentration | Dependence on Gulf region for styrene monomer creates structural vulnerability; alternative sourcing is more expensive (higher freight, longer lead times), impacting cost structure even if global prices stabilize. |
Q&A Highlights
Demand Destruction & Volume Decline
Question: Was the demand decline from non-OEM segment genuine, or did imports take market share? (Aditya Khetan, SMIFS)
Answer: Non-OEM demand was genuinely down
50% due to high prices and gas supply issues for downstream processors. Imports (20,000 tons) were in line with historical run-rate (87,000 tons annual last year) but were inflated by the temporary duty waiver. OEM demand was stable/marginally better. (Rakesh Nayyar)Question: Did the industry experience similar declines, or was Supreme Petrochem's degrowth worse? (Santosh Keshri, SKK Huf)
Answer: Polystyrene industry degrew at the same rate; EPS declines were lesser for the company. Capacity expansion decisions are based on long-term India growth story and export possibilities, not one quarter's temporary events. (Rakesh Nayyar)
Margin Sustainability & Global Deltas
Question: What is the sustainability of the 19% EBITDA margin? (Aditya Khetan, SMIFS)
Answer: Margins depend on global deltas. Q1 deltas were exceptional (GPPS +$300+, HIPS +$400+ vs. normal $200 and $275-300 respectively). These are "aberrations" driven by the crisis and will normalize over time as global deltas settle. (Rakesh Nayyar)
Question: Can you quantify current deltas after normalization? (Vipul Shah, Sumangal Investments)
Answer: Current delta for GPPS is $250-275, HIPS ~$350. During June's temporary peace accord, polymer prices fell sharply; deltas have improved slightly after renewed hostilities but not to Q1 peak levels. (Rakesh Nayyar)
Raw Material Sourcing & Cost Impact
- Question: Are alternate sourcing arrangements structurally more expensive than traditional Gulf supplies? (Sahil Sen, Individual Investor)
- Answer: Yes. Gulf supplies involve 4-7 day voyages; alternate sources involve longer voyage times, shipping availability constraints, and higher freight rates. Even at same material prices, shipping costs increase, impacting margins. Management declined to quantify impact given fluid situation. (Rakesh Nayyar)
Capacity Expansion & Capex Allocation
Question: How is the ~₹900 crores capex allocated across projects? (Aditya Khetan, SMIFS)
Answer: The ₹900 crores includes the 150,000 m³ XPS board line, compounding expansion (50,000 to 80,000 TPA), and the new 80,000 TPA PS line at Amdoshi. All funded through internal accruals; all capacities on board by March 2029. (Rakesh Nayyar)
Question: What asset turnover can be expected from new expansions? (Vipul Shah, Sumangal Investments)
Answer: All products combined on full capacity basis will generate 2x asset turnover. Terminal ABS capacity after full expansion will be 140,000 tons nameplate. (Rakesh Nayyar)
Compounding Business Strategy
- Question: How will Supreme Petrochem compete given competitors offer 40-50 day credit terms? (Sailesh Raja, 360 ONE Capital Market)
- Answer: Company will maintain credit discipline, focusing on value-added grades and customers who respect credit terms. Growth may come slower but will be sustainable. ABS compounds performing very well, with significant growth expected. Compounding capacity (80,000 TPA) expected to be fully utilized within 2-3 years of commissioning (June 2027). (Rakesh Nayyar)
EPS Demand & Exports
- Question: How will the expanded EPS capacity (143,000 TPA) be filled given exports are on hold? (Sailesh Raja, 360 ONE Capital Market)
- Answer: EPS grade approvals for Europe secured and small export quantities shipped last year. Exports currently on hold due to shipping disruptions, Red Sea issues, and limited styrene availability. Domestic demand growth from energy-efficient buildings, cold storage, coal supply chain, and construction will drive utilization. Once situation normalizes, EPS exports to Europe will resume and grow. (Rakesh Nayyar)
Key Takeaway
Supreme Petrochem reported exceptionally strong Q1 FY27 financials—revenue of ₹1,693 crores (+22% YoY), EBITDA of ₹331 crores (+188% YoY, 19.53% margin), and PAT of ₹236 crores (13.96% margin)—driven entirely by widened international deltas amid the West Asia crisis, not volume growth (volumes fell 24.5% YoY to 70,842 MT). The company demonstrated supply chain resilience by meeting all domestic customer requirements despite all three Gulf styrene suppliers suspending operations, though exports collapsed to 10-12% of normal levels. Management explicitly characterized Q1 margins as an "aberration" expected to normalize as global deltas revert ($250-275 GPPS, ~$350 HIPS currently vs. $300+/$400+ peaks). Strategically, the company is investing ~₹900 crores (internal accruals) in capacity expansions—EPS Phase 2 completed (143,000 TPA), new 150,000 m³ XPS board line, compounding expansion to 80,000 TPA (both by June 2027), and new 80,000 TPA PS line (December 2028, total PS capacity to 380,000 TPA)—while shifting product mix toward higher-margin ABS compounds and value-added specialty grades with disciplined credit terms. Key watch points include West Asia resolution timing, non-OEM demand recovery (now returning), import duty policy stability, and whether elevated styrene prices sustain or erode downstream demand.